LT
Leal Therapeutics
United States · Biotech · Healthtech
Develops neuro-metabolic therapeutics for schizophrenia and ALS
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $30M | Alexandria Venture Investments — Role not disclosedChugai Venture Fund — Role not disclosedEli Lilly and Company — Role not disclosedEuclidean Capital — Role not disclosedNewpath Partners — Role not disclosedOrbiMed — Role not disclosedPhiFund — Role not disclosedSV Health Investors' Dementia Discovery Fund — Role not disclosed |